Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin plus heparin for unexplained recurrent pregnancy loss
ACTRN12614000698673Phase 4Completed
- Sponsor
- Ahmed Maged
- Start
- Jun 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin and heparin in recurrent miscarriage (RPL) (2 arms), sponsored by Ahmed Maged. Primary endpoint: Number of patients who completed their first trimester. Started Jun 2011; status: completed.
02
Drugs
aspirinheparin
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on ACTRN12614000698673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000698673.